Filing Details
- Accession Number:
- 0001570562-24-000095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-06 19:01:24
- Reporting Period:
- 2024-06-04
- Accepted Time:
- 2024-06-06 19:01:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1570562 | Evolus Inc. | EOLS | Pharmaceutical Preparations (2834) | 461385614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1700836 | David Moatazedi | 520 Newport Center Dr. Suite 1200 Newport Beach CA 92660 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-06-04 | 140,214 | $12.73 | 533,349 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-06-05 | 155,278 | $5.46 | 688,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-05 | 155,278 | $12.92 | 533,349 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-06-06 | 175,940 | $7.28 | 709,289 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-06 | 175,940 | $12.59 | 533,349 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-06-05 | 155,278 | $0.00 | 155,278 | $5.46 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-06-06 | 175,940 | $0.00 | 175,940 | $7.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 155,281 | 2032-01-25 | No | 4 | M | Direct | |
| 1,006,079 | 2028-05-06 | No | 4 | M | Direct |
Footnotes
- The shares were sold in multiple trades at prices ranging from $12.70 to $12.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The shares were sold in multiple trades at prices ranging from $12.77 to $13.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The shares were sold in multiple trades at prices ranging from $12.40 to $12.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The shares subject to the option vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
- The shares subject to the option vested in full over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
Billionaire Hedge Funds
